|
|
|||||
| INSTITUTE for ULTRAFAST SPECTROSCOPY AND LASERS and NEW YORK STATE CENTER FOR ADVANCED TECHNOLOGY for ULTRAFAST PHOTONIC MATERIALS AND APPLICATIONS | ||||||
| Breakthrough in Detecting Cancerous Tissue via Stokes Shift Emission Spectroscopy | ||||||
|
(Nov. 24, 2003) A research team at City College's Institute for Ultrafast Spectroscopy and Lasers (IUSL) headed by Dr. Robert R. Alfano has announced development of a new technique that is much more sensitive than conventional fluorescence Spectroscopy to detect cancerous bio-molecules and structures. Called "Stokes Shift Emission Spectroscopy," the method grows out of seminal work done at the IUSL for the past two decades. In 1984. IUSL researchers first demonstrated that light could be used to detect cancer from key molecules without removing tissue. According to Dr. Alfano, "this revolutionary breakthrough will make optical biopsy the new medical frontier for cancer diagnosis and other medical applications." The emission and absorption of organic molecules in different hosts has been investigated for over fifty years. Information on molecules in different states of matter has been obtained by measuring emission and absorption spectra. For over four decades spectroscopy has played an important role in understanding the fundamental processes that occur in biology, chemistry and solid-slate physics. Since the discoveries at the IUSL in 1984, spectroscopy has been investigated as a tool to separate cancer, benign and surrounding tissue regions. Typically, tissue is excited at a given wavelength to emit radiation at different wavelengths, which are then used to characterize the tissue. The emission wavelengths serve as "spectral fingerprints" for changes in the structure and content of various proteins in the tissue. "For organic molecules, typically, the peaks of absorption and emission occur at different wavelengths," Dr. Alfano said, "and the emission band occurs at lower energy than the excitation band." This difference between the emission and absorption peaks, known as the Stokes Shift, depends in part on the polarity of the host environment surrounding the emitting organic molecule. The new detection method developed at the IUSL combines the fluorescence and absorption spectra of molecules in tissue and is known as "Stokes Shift Emission Spectroscopy." "The excitation and emission wavelengths are scanned simultaneously with a fixed value between the excitation and emission wavelengths," according to Dr. Alfano. "This approach is much more sensitive than ordinary fluorescence spectroscopy and has delivered dramatically improved results in detecting changes in native bio-molecules. It offers great promise, therefore, in detecting cancerous, pre-cancerous and normal tissues." When comparing the effectiveness of the Stokes Shift Emission Spectroscopy (SS) method with conventional fluorescence spectroscopy it is clear that this method is a more selective and a more effective means of distinguishing cancerous from normal tissue. Dr. Alfano called this as a "giant step forward for scientists at the IUSL," who pioneered using optical spectroscopy to diagnose cancer without removing tissue. The latest advance has the potential to detect tumors involving the breast, cervix, gastrointestinal tract, head and neck, prostate, liver, brain, kidney, bladder and other organs. This work has been supported, in part, by Mediscience Technology Corp. and funds from organized research at The City University of New York. | ||||||